YahooAugust 14, 2026 at 11:11 AM NY2 Months Ago
Krystal Biotech Seen Positioned for Further Gains on Vyjuvek, Pipeline Readouts, RBC Says
Krystal Biotech (KRYS) has further room for gains driven by Vyjuvek, its treatment for the rare blis
Read the Full Story at the Source
The summary here comes from the news provider; the rest of the article lives on the publisher's site: Yahoo
